当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:276.78亿  总市值:468.46亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金3,823,275,963.5936,933,180,960.4128,433,944,110.919,901,637,776.77
收到其他与经营活动有关的现金23,179,926.73139,707,254.0481,168,614.263,260,080.32
经营活动现金流入的平衡项目0000
经营活动现金流入小计3,846,455,890.3237,072,888,214.4528,515,112,725.119,964,897,857.09
购买商品、接受劳务支付的现金2,439,691,420.1935,476,050,758.7726,712,896,152.9516,837,800,522.01
支付给职工以及为职工支付的现金513,121,152.571,809,219,214.871,352,024,739.43860,258,863.68
支付的各项税费103,390,316.692,070,230,637.591,841,854,981.931,506,554,938.71
支付其他与经营活动有关的现金486,097,911.12,131,376,918.421,673,305,575.521,067,605,374.58
经营活动现金流出的平衡项目0000
经营活动现金流出小计3,542,300,800.5541,486,877,529.6531,580,081,449.8320,272,219,698.98
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额304,155,089.77-4,413,989,315.2-3,064,968,724.73-307,321,841.89
二、投资活动产生的现金流量:
收回投资收到的现金4,000,000---
处置固定资产、无形资产和其他长期资产收回的现金净额6,364,945.64,759,655.974,655,142.174,641,142.17
投资活动现金流入的平衡项目0000
投资活动现金流入小计10,364,945.64,759,655.974,655,142.174,641,142.17
购建固定资产、无形资产和其他长期资产支付的现金149,039,120.66930,343,067.65700,478,076.61427,713,652.42
投资活动现金流出的平衡项目0000
投资活动现金流出小计149,039,120.66930,343,067.65700,478,076.61427,713,652.42
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-138,674,175.06-925,583,411.68-695,822,934.44-423,072,510.25
三、筹资活动产生的现金流量:
取得借款收到的现金5,944,415,356.7214,738,177,057.9410,264,152,391.265,897,486,152
收到其他与筹资活动有关的现金59,6001,162,393.71,159,935.2832,135.2
筹资活动现金流入平衡项目0000
筹资活动现金流入小计5,944,474,956.7214,739,339,451.6410,265,312,326.465,898,318,287.2
偿还债务支付的现金5,675,011,084.2610,198,541,3037,271,638,2675,555,296,410
分配股利、利润或偿付利息支付的现金62,785,984.652,527,812,210.421,998,082,020.6259,156,202.82
支付其他与筹资活动有关的现金4,233,575.99315,099,068.05310,952,729.18307,576,298.04
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,742,030,644.913,041,452,581.479,580,673,016.85,922,028,910.86
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额202,444,311.821,697,886,870.17684,639,309.66-23,710,623.66
四、汇率变动对现金及现金等价物的影响-122,611.31,252,023.78-801,413.27534,612.59
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额367,802,615.23-3,640,433,832.93-3,076,953,762.78-753,570,363.21
加:期初现金及现金等价物余额2,698,856,401.986,339,290,234.916,339,290,234.916,339,290,234.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,066,659,017.212,698,856,401.983,262,336,472.135,585,719,871.7
补充资料:
净利润-2,018,478,513.91-2,234,319,364.61
资产减值准备-655,340,773.1-408,676,854.79
固定资产和投资性房地产折旧-348,442,188.25-175,104,263.64
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-348,442,188.25-175,104,263.64
无形资产摊销-27,346,564.24-12,102,480.28
长期待摊费用摊销-16,235,199.86-7,469,743.84
处置固定资产、无形资产和其他长期资产的损失--46,946.97--95,411.72
固定资产报废损失-362,278.84-152,505.07
财务费用-141,498,348.61-49,905,385.9
递延所得税--372,957,916.55--189,622,489.17
其中:递延所得税资产减少--359,306,509.09--185,409,052.72
递延所得税负债增加--13,651,407.46--4,213,436.45
存货的减少--13,253,831,856.99--6,687,227,058.8
经营性应收项目的减少-10,172,547,509.29-1,209,614,112.43
经营性应付项目的增加--4,180,133,372.66-2,466,127,346.84
现金的期末余额-2,698,856,401.98-5,585,719,871.7
减:现金的期初余额-6,339,290,234.91-6,339,290,234.91
公告日期2025-04-222025-04-222024-10-262024-08-30
审计意见(境内)标准无保留意见
TOP↑